- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Senior Leadership of TruTrace Technologies Presents at Deloitte Cannabis Summit
TruTrace Technologies Inc. (TSXV:TTT, OTC PINK: BKKSF) (“TruTrace” or the “Company”), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, is pleased to announce that its Chief Executive Officer, Robert Galarza, and Chief Technology Officer.
TruTrace Technologies Inc. (TSXV:TTT, OTC PINK: BKKSF) (“TruTrace” or the “Company”), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, is pleased to announce that its Chief Executive Officer, Robert Galarza, and Chief Technology Officer. Tommy Stephenson, took part in a formal presentation before an international audience at the 2019 Deloitte Greenhouse™ Cannabis Summit on June 4th in Toronto to discuss innovations and initiatives which are designed to bring greater transparency and collaboration to the cannabis industry.
The invitation-only event took place following the release of Deloitte’s third annual report on the impact of cannabis legalization on the Canadian economy: Nurturing new growth: Canada gets ready for Cannabis 2.
TruTrace Technologies was given the opportunity to showcase its proprietary StrainSecure™ platform and discussed how it could work with secondary systems, such as Deloitte’s prototype Cannabis Related Network tool, to bring additional transparency to the supply chain of cannabis. This informative session highlighted how Deloitte is supporting companies like TruTrace in providing integrity due diligence services on individuals and entities to manufacturers, distributors, regulatory bodies, financial institutions and other stakeholders in the medical and recreational Cannabis supply chain to better identify, verify, track and trace cannabis products.
“We were delighted to be able to showcase our platform at this bellwether industry event,” said TruTrace Technologies CEO Robert Galarza. “Although Deloitte is a brand synonymous with integrity—whether relating to financial security, anti-money laundering or risk management—what impressed us the most was their dedication to technological innovation and intelligent data.”
“The Deloitte Greenhouse is about sharing innovative technologies and ideas, where the StrainSecure™ platform demonstrated how it satisfies current challenges in the Cannabis supply chain. Thank you to David Stewart, Margie Peeters, Alice Lin and the entire Deloitte team for their hospitality.”
For more information and to read the full Deloitte 2019 cannabis report, please visit: Nurturing new growth
About TruTrace Technologies:
TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated and permanent account for cannabis strains from ownership to market.
About Deloitte
Deloitte provides audit & assurance, consulting, financial advisory, risk advisory, tax and related services to public and private clients spanning multiple industries. Deloitte serves four out of five Fortune Global 500® companies through a globally connected network of member firms in more than 150 countries and territories bringing world-class capabilities, insights and service to address clients’ most complex business challenges. To learn more about how Deloitte’s approximately 264,000 professionals—9,400 of whom are based in Canada—make an impact that matters, please connect with us on LinkedIn, Twitter or Facebook.
Deloitte LLP, an Ontario limited liability partnership, is the Canadian member firm of Deloitte Touche Tohmatsu Limited. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.
Disclaimer for Forward-Looking Information
Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company, including the statements regarding how the StrainSecure™ platform could work with secondary systems, such as the Deloitte Intelligence Database, to bring additional transparency to the supply chain of cannabis. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Forward-looking information necessarily involves known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canadagenerally and other risks Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information contained in this news release.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
For further information: TruTrace Technologies Inc: Robert Galarza, Chief Executive Officer and Director; Media Relations: Corey Herscu, RNMKR Agency, 416-300-3030, corey@rnmkr.agency; Investor Inquiries: Crystal Quast, Bullseye Corporate, 1-844-656-3629, Quast@bullseyecorporate.com
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.